Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / GLOBAL EX US HGH
-
Total 13F shares
-
5,101,807
-
Share change
-
-1,560,535
-
Total reported value
-
$101,736,859
-
Price per share
-
$19.94
-
Number of holders
-
63
-
Value change
-
-$32,684,786
-
Number of buys
-
27
-
Number of sells
-
35
Institutional Holders of INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) as of Q1 2022
As of 31 Mar 2022,
INVESCO EXCH TRADED FD TR II - GLOBAL EX US HGH (PGHY) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,101,807 shares.
The largest 10 holders included
Whitcomb & Hess, Inc., Cerity Partners LLC, CABOT WEALTH MANAGEMENT INC, JANE STREET GROUP, LLC, PFS INVESTMENTS INC., Essex LLC, Hightower 6M Holding, LLC, Royal Fund Management, LLC, MORGAN STANLEY, and Advisory Alpha, LLC.
This page lists
63
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.